# Study to Evaluate the Safety and Efficacy of Switching Calcineurin Inhibitor to Everolimus After Kidney Transplantation in Adults

> **NCT01455649** · PHASE4 · UNKNOWN · sponsor: **Deise de Boni Monteiro de Carvalho** · enrollment: 30 (estimated)

## Conditions studied

- Kidney Transplant
- Immunosuppression

## Interventions

- **DRUG:** Everolimus
- **DRUG:** calcineurin inhibitor

## Key facts

- **NCT ID:** NCT01455649
- **Lead sponsor:** Deise de Boni Monteiro de Carvalho
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-11
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2011-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01455649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01455649, "Study to Evaluate the Safety and Efficacy of Switching Calcineurin Inhibitor to Everolimus After Kidney Transplantation in Adults". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01455649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*